Alanquihan, Eufracia L.
HRN: 21-33-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/28/2022
06/03/2022
IVTT
4.5g
Q6
Sepsis
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes